Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.

[1]  A. Belldegrun,et al.  Prognostic impact of preoperative neutrophil-to-lymphocyte ratio in localized nonclear cell renal cell carcinoma. , 2013, The Journal of urology.

[2]  J. Cheville,et al.  The SPARC score: a multifactorial outcome prediction model for patients undergoing radical cystectomy for bladder cancer. , 2013, The Journal of urology.

[3]  A. Hemal,et al.  Preoperative neutrophil/lymphocyte ratio predicts overall survival and extravesical disease in patients undergoing radical cystectomy. , 2013, Journal of endourology.

[4]  Y. Iwasaki,et al.  Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients with colorectal cancer , 2013, British Journal of Cancer.

[5]  Anirban P. Mitra,et al.  Unaltered oncological outcomes of radical cystectomy with extended lymphadenectomy over three decades , 2013, BJU international.

[6]  K. Pummer,et al.  Validation of the pre-treatment neutrophil–lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients , 2013, British Journal of Cancer.

[7]  Y. Horiguchi,et al.  Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy. , 2012, Urology.

[8]  D. Wood.  Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort. , 2011, The Journal of urology.

[9]  D. Talwar,et al.  A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. , 2011, European journal of cancer.

[10]  Kazutaka Saito,et al.  C-reactive protein as a biomarker for urological cancers , 2011, Nature Reviews Urology.

[11]  V. Bhatt,et al.  Usefulness of the Neutrophil-to-Lymphocyte Ratio in Predicting Short- and Long-Term Mortality in Breast Cancer Patients , 2011, Annals of Surgical Oncology.

[12]  C. Stief,et al.  Lymph node density affects cancer-specific survival in patients with lymph node-positive urothelial bladder cancer following radical cystectomy. , 2011, European urology.

[13]  S. Phillips,et al.  Effect of preoperative nutritional deficiency on mortality after radical cystectomy for bladder cancer. , 2011, The Journal of urology.

[14]  J. Nakashima,et al.  Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of recurrence in patients with nonmetastatic renal cell carcinoma. , 2010, The Journal of urology.

[15]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[16]  C. Compton,et al.  The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM , 2010, Annals of Surgical Oncology.

[17]  A. Nicholson,et al.  Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. , 2009, The Journal of thoracic and cardiovascular surgery.

[18]  M. Ghoneim,et al.  Radical cystectomy for carcinoma of the bladder: 2,720 consecutive cases 5 years later. , 2008, The Journal of urology.

[19]  P. Allavena,et al.  Cancer-related inflammation , 2008, Nature.

[20]  Sung Hoon Kim,et al.  Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment , 2008, Cancer Immunology, Immunotherapy.

[21]  Shigemi Matsumoto,et al.  The Baseline Ratio of Neutrophils to Lymphocytes Is Associated with Patient Prognosis in Advanced Gastric Cancer , 2008, Oncology.

[22]  W. See.  Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer , 2007 .

[23]  Yair Lotan,et al.  Nomograms Provide Improved Accuracy for Predicting Survival after Radical Cystectomy , 2006, Clinical Cancer Research.

[24]  Yair Lotan,et al.  Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder. , 2006, The Journal of urology.

[25]  C. Dinney.  Therapy of invasive bladder cancer. , 2006, Urology.

[26]  S. Groshen,et al.  Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  M. Yu,et al.  Non-steroidal anti-inflammatory drugs and bladder cancer prevention , 2000, British Journal of Cancer.